Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 959

1.

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Laurent C, Nicolae A, Laurent C, Le Bras F, Haioun C, Fataccioli V, Amara N, Adélaïde J, Guille A, Schiano JM, Tesson B, Traverse-Glehen A, Chenard MP, Mescam L, Moreau A, Chassagne-Clement C, Somja J, Escudié F, André M, Martin N, Lacroix L, Lemonnier F, Hamy-Petit AS, Reyal F, Bannier M, Oberic L, Prade N, Frénois FX, Beldi-Ferchiou A, Delfau-Larue MH, Bouabdallah R, Birnbaum D, Brousset P, Xerri L, Gaulard P.

Blood. 2019 Nov 27. pii: blood.2019001904. doi: 10.1182/blood.2019001904. [Epub ahead of print]

PMID:
31774495
2.

MARCKS protein overexpression is associated with poor prognosis in male breast cancer.

Manai M, Abdeljaoued S, Goucha A, Adouni O, Bettaieb I, Bouzaien H, Rahal K, Birnbaum D, Bertucci F, Gamoudi A.

Cancer Biomark. 2019 Nov 13. doi: 10.3233/CBM-190637. [Epub ahead of print]

PMID:
31771045
3.

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma.

Billon E, Finetti P, Bertucci A, Niccoli P, Birnbaum D, Mamessier E, Bertucci F.

Oncoimmunology. 2019 Aug 28;8(11):e1655362. doi: 10.1080/2162402X.2019.1655362. eCollection 2019.

PMID:
31646101
4.

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.

Garciaz S, N'guyen Dasi L, Finetti P, Chevalier C, Vernerey J, Poplineau M, Platet N, Audebert S, Pophillat M, Camoin L, Bertucci F, Calmels B, Récher C, Birnbaum D, Chabannon C, Vey N, Duprez E.

Clin Epigenetics. 2019 Oct 12;11(1):141. doi: 10.1186/s13148-019-0738-6.

5.

Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Cervera N, Lhoumeau AC, Adélaïde J, Guille A, Murati A, Mozziconacci MJ, Vey N, Birnbaum D, Gelsi-Boyer V.

Haematologica. 2019 Oct 10. pii: haematol.2019.231142. doi: 10.3324/haematol.2019.231142. [Epub ahead of print]

6.

Machine-Learning Classification Suggests That Many Alphaproteobacterial Prophages May Instead Be Gene Transfer Agents.

Kogay R, Neely TB, Birnbaum DP, Hankel CR, Shakya M, Zhaxybayeva O.

Genome Biol Evol. 2019 Oct 1;11(10):2941-2953. doi: 10.1093/gbe/evz206.

7.

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells.

Arfaoui A, Rioualen C, Azzoni V, Pinna G, Finetti P, Wicinski J, Josselin E, Macario M, Castellano R, Léonard-Stumpf C, Bal A, Gros A, Lossy S, Kharrat M, Collette Y, Bertucci F, Birnbaum D, Douik H, Bidaut G, Charafe-Jauffret E, Ginestier C.

EMBO Mol Med. 2019 Oct;11(10):e9930. doi: 10.15252/emmm.201809930. Epub 2019 Sep 2.

8.

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.

de Nonneville A, Finetti P, Adelaide J, Lambaudie É, Viens P, Gonçalves A, Birnbaum D, Mamessier E, Bertucci F.

Cancers (Basel). 2019 Aug 13;11(8). pii: E1158. doi: 10.3390/cancers11081158.

9.

Learning Curve in Laparoscopic Liver Resection, Educational Value of Simulation and Training Programmes: A Systematic Review.

Guilbaud T, Birnbaum DJ, Berdah S, Farges O, Beyer Berjot L.

World J Surg. 2019 Nov;43(11):2710-2719. doi: 10.1007/s00268-019-05111-x. Review.

PMID:
31384997
10.

Targeted molecular characterization shows differences between primary and secondary myelofibrosis.

Courtier F, Garnier S, Carbuccia N, Guille A, Adélaide J, Chaffanet M, Hirsch P, Paz DL, Slama B, Vey N, Ugo V, Delhommeau F, Rey J, Birnbaum D, Murati A.

Genes Chromosomes Cancer. 2019 Jul 24. doi: 10.1002/gcc.22789. [Epub ahead of print]

PMID:
31340059
11.

Author Correction: Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 Aug;572(7767):E7. doi: 10.1038/s41586-019-1380-3.

PMID:
31308536
12.

Sensitive and easy screening for circulating tumor cells by flow cytometry.

Lopresti A, Malergue F, Bertucci F, Liberatoscioli ML, Garnier S, DaCosta Q, Finetti P, Gilabert M, Raoul JL, Birnbaum D, Acquaviva C, Mamessier E.

JCI Insight. 2019 Jun 13;5. pii: 128180. doi: 10.1172/jci.insight.128180.

13.

Assessment of a Vacuum-Based Intra-Colonic Diverting Device: A Preclinical Study.

Khosrovani C, Birnbaum DJ, Berdah S, Beyer-Berjot L.

Surg Innov. 2019 Oct;26(5):581-587. doi: 10.1177/1553350619851670. Epub 2019 Jun 11.

PMID:
31185816
14.

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease.

Mari R, Mamessier E, Lambaudie E, Provansal M, Birnbaum D, Bertucci F, Sabatier R.

Cancers (Basel). 2019 Jun 4;11(6). pii: E774. doi: 10.3390/cancers11060774. Review.

15.

Glucagonoma with Paraneoplasic Dermatitis: Diagnosis and Management.

Guilbaud T, Berbis P, Birnbaum DJ.

J Gastrointest Surg. 2019 May 31. doi: 10.1007/s11605-019-04267-0. [Epub ahead of print] No abstract available.

PMID:
31152349
16.

PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.

Bertucci F, Finetti P, Monneur A, Perrot D, Chevreau C, Le Cesne A, Blay JY, Mir O, Birnbaum D.

Mol Oncol. 2019 Jul;13(7):1577-1588. doi: 10.1002/1878-0261.12522. Epub 2019 Jun 7.

17.

Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 May;569(7757):560-564. doi: 10.1038/s41586-019-1056-z. Epub 2019 May 22. Erratum in: Nature. 2019 Aug;572(7767):E7.

PMID:
31118521
18.

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.

Tyran M, Carbuccia N, Garnier S, Guille A, Adelaïde J, Finetti P, Toulzian J, Viens P, Tallet A, Goncalves A, Metellus P, Birnbaum D, Chaffanet M, Bertucci F.

Cancers (Basel). 2019 May 13;11(5). pii: E665. doi: 10.3390/cancers11050665.

19.

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma.

Birnbaum DJ, Finetti P, Birnbaum D, Mamessier E, Bertucci F.

J Clin Med. 2019 Apr 30;8(5). pii: E596. doi: 10.3390/jcm8050596.

20.

Congo Red Fluorescence for Rapid In Situ Characterization of Synthetic Curli Systems.

Kan A, Birnbaum DP, Praveschotinunt P, Joshi NS.

Appl Environ Microbiol. 2019 Jun 17;85(13). pii: e00434-19. doi: 10.1128/AEM.00434-19. Print 2019 Jul 1.

PMID:
31003987
21.

Reply to: The cystic duct syndrome is still actual.

Guilbaud T, Birnbaum DJ.

Surgery. 2019 Dec;166(6):1198-1199. doi: 10.1016/j.surg.2019.03.001. Epub 2019 Apr 9. No abstract available.

PMID:
30979426
22.

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer.

Daulat AM, Finetti P, Revinski D, Silveira Wagner M, Camoin L, Audebert S, Birnbaum D, Kodjabachian L, Borg JP, Bertucci F.

Br J Cancer. 2019 Apr;120(9):931-940. doi: 10.1038/s41416-019-0448-z. Epub 2019 Apr 11.

23.

Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors.

Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E.

Cancers (Basel). 2019 Apr 8;11(4). pii: E497. doi: 10.3390/cancers11040497.

24.

ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2.

Lévêque R, Corbet C, Aubert L, Guilbert M, Lagadec C, Adriaenssens E, Duval J, Finetti P, Birnbaum D, Magné N, Chopin V, Bertucci F, Le Bourhis X, Toillon RA.

Cancer Lett. 2019 May 1;449:196-206. doi: 10.1016/j.canlet.2019.02.019. Epub 2019 Feb 13.

PMID:
30771434
25.

Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results.

Manai M, Finetti P, Mejri N, Athimni S, Birnbaum D, Bertucci F, Rahal K, Gamoudi A, Chaffanet M, Manai M, Boussen H.

Mol Clin Oncol. 2019 Feb;10(2):223-230. doi: 10.3892/mco.2018.1773. Epub 2018 Nov 26.

26.

Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis.

Wanquet A, Courtier F, Guille A, Carbuccia N, Garnier S, Adélaide J, Gelsi-Boyer V, Mozziconacci MJ, Rey J, Vey N, Birnbaum D, Murati A.

Leuk Lymphoma. 2019 May;60(5):1289-1293. doi: 10.1080/10428194.2018.1522437. Epub 2019 Jan 2. No abstract available.

PMID:
30601073
27.

Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade.

Bertucci F, Finetti P, Monneur A, Birnbaum D.

Ann Oncol. 2019 Feb 1;30(2):342-343. doi: 10.1093/annonc/mdy528. No abstract available.

PMID:
30535178
28.

Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.

Xerri L, Adélaïde J, Avenin M, Guille A, Taix S, Bonnet N, Carbuccia N, Garnier S, Mescam L, Murati A, Chaffanet M, Coso D, Bouabdallah R, Bertucci F, Birnbaum D.

Histopathology. 2019 Mar;74(4):654-662. doi: 10.1111/his.13783. Epub 2019 Jan 31.

PMID:
30393995
29.

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.

Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D.

Br J Cancer. 2018 Nov;119(11):1383-1391. doi: 10.1038/s41416-018-0309-1. Epub 2018 Oct 24.

30.

Thomas Mann and Neurology.

Caputi N, Birnbaum D, Boller F.

Front Neurol Neurosci. 2018;43:76-84. doi: 10.1159/000490406. Epub 2018 Oct 18.

PMID:
30336458
31.

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Pophillat M, Granjeaud S, Fourquet P, Jacot W, Tarpin C, Sabatier R, Agavnian E, Finetti P, Adelaide J, Birnbaum D, Ginestier C, Charafe-Jauffret E, Viens P, Bertucci F, Borg JP, Camoin L.

Oncotarget. 2018 Sep 18;9(73):33762-33777. doi: 10.18632/oncotarget.26031. eCollection 2018 Sep 18.

32.

Preoperative Biliary Stenting and Major Morbidity After Pancreatoduodenectomy: Does Elapsed Time Matter?: The FRAGERITA Study Group.

Sandini M, Honselmann KC, Birnbaum DJ, Gavazzi F, Chirica M, Wellner U, Guilbaud T, Bolm L, Angrisani M, Moutardier V, Cereda M, Girard É, Montorsi M, Keck T, Zerbi A, Gianotti L.

Ann Surg. 2018 Nov;268(5):808-814. doi: 10.1097/SLA.0000000000002838.

PMID:
30303874
33.

Mutation of FOP/FGFR1OP in mice recapitulates human short rib-polydactyly ciliopathy.

Cabaud O, Roubin R, Comte A, Bascunana V, Sergé A, Sedjaï F, Birnbaum D, Rosnet O, Acquaviva C.

Hum Mol Genet. 2018 Oct 1;27(19):3377-3391. doi: 10.1093/hmg/ddy246.

PMID:
29982567
34.

CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors.

Mamessier E, Birnbaum DJ, Finetti P, Birnbaum D, Bertucci F.

Ann Transl Med. 2018 Feb;6(3):54. doi: 10.21037/atm.2017.11.26. No abstract available.

35.

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.

Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):248-255. doi: 10.1016/j.bbcan.2018.02.001. Epub 2018 Feb 28. Review.

PMID:
29499330
36.

C-Reactive Protein on Postoperative Day 1 Is a Reliable Predictor of Pancreas-Specific Complications After Pancreaticoduodenectomy.

Guilbaud T, Birnbaum DJ, Lemoine C, Chirica M, Risse O, Berdah S, Girard E, Moutardier V.

J Gastrointest Surg. 2018 May;22(5):818-830. doi: 10.1007/s11605-017-3658-9. Epub 2018 Jan 4.

PMID:
29327310
37.

"Wnt/β-Catenin in GIST"-Letter.

Bertucci F, Finetti P, De Nonneville A, Birnbaum D.

Mol Cancer Ther. 2018 Jan;17(1):327-328. doi: 10.1158/1535-7163.MCT-17-0948.

38.

Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.

Doghri R, Manai M, Finetti P, Driss M, Agavnian E, Lopez M, Elghardallou M, Charafe-Jauffret E, Manai M, Chaffanet M, Birnbaum D, Mrad K, Bertucci F.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E41. doi: 10.3390/ijms19010041.

39.

[Triple-negative breast cancer therapy via nectin-4 targeting].

M-Rabet M, Bertucci F, Birnbaum D, Lopez M.

Med Sci (Paris). 2017 Nov;33(11):936-939. doi: 10.1051/medsci/20173311007. Epub 2017 Dec 4. French. No abstract available.

40.

CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.

Xerri L, Adélaïde J, Popovici C, Garnier S, Guille A, Mescam-Mancini L, Laurent C, Brousset P, Coze C, Michel G, Chaffanet M, Bouabdallah R, Coso D, Bertucci F, Birnbaum D.

Am J Surg Pathol. 2018 Feb;42(2):150-159. doi: 10.1097/PAS.0000000000000989.

PMID:
29194093
41.

Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms.

Venton G, Courtier F, Charbonnier A, D'incan E, Saillard C, Mohty B, Mozziconacci MJ, Birnbaum D, Murati A, Vey N, Rey J.

Am J Hematol. 2018 Mar;93(3):330-338. doi: 10.1002/ajh.24973. Epub 2017 Dec 6.

42.

Pancreatectomy for pancreatic incidentaloma: What are the risks?

Bouquot M, Gaujoux S, Cauchy F, Birnbaum D, Dokmak S, Levy P, Soubrane O, Sauvanet A.

Pancreatology. 2018 Jan;18(1):114-121. doi: 10.1016/j.pan.2017.11.002. Epub 2017 Nov 7.

PMID:
29146108
43.

Charles Bonnet Syndrome and Other Hallucinatory Phenomena.

Boller F, Birnbaum DS, Caputi N.

Front Neurol Neurosci. 2018;41:117-124. doi: 10.1159/000475702. Epub 2017 Nov 16. Review.

PMID:
29145190
44.

Validation and comparison of the molecular classifications of pancreatic carcinomas.

Birnbaum DJ, Finetti P, Birnbaum D, Mamessier E, Bertucci F.

Mol Cancer. 2017 Nov 6;16(1):168. doi: 10.1186/s12943-017-0739-z.

45.

The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.

Bertucci F, De Nonneville A, Finetti P, Perrot D, Nilbert M, Italiano A, Le Cesne A, Skubitz KM, Blay JY, Birnbaum D.

Ann Oncol. 2018 Feb 1;29(2):459-465. doi: 10.1093/annonc/mdx699.

PMID:
29069276
46.

Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas-Letter.

Bertucci F, Finetti P, Birnbaum D.

Mol Cancer Ther. 2017 Oct;16(10):2324. doi: 10.1158/1535-7163.MCT-17-0491. No abstract available.

47.

Salinomycin kills cancer stem cells by sequestering iron in lysosomes.

Mai TT, Hamaï A, Hienzsch A, Cañeque T, Müller S, Wicinski J, Cabaud O, Leroy C, David A, Acevedo V, Ryo A, Ginestier C, Birnbaum D, Charafe-Jauffret E, Codogno P, Mehrpour M, Rodriguez R.

Nat Chem. 2017 Oct;9(10):1025-1033. doi: 10.1038/nchem.2778. Epub 2017 May 16.

48.

A 25-gene classifier predicts overall survival in resectable pancreatic cancer.

Birnbaum DJ, Finetti P, Lopresti A, Gilabert M, Poizat F, Raoul JL, Delpero JR, Moutardier V, Birnbaum D, Mamessier E, Bertucci F.

BMC Med. 2017 Sep 20;15(1):170. doi: 10.1186/s12916-017-0936-z.

49.

Flick the cancer stem cells' switch to turn cancer off.

Ginestier C, Birnbaum D, Charafe-Jauffret E.

Mol Cell Oncol. 2017 Apr 28;4(4):e1319896. doi: 10.1080/23723556.2017.1319896. eCollection 2017.

50.

Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.

Cervera N, Carbuccia N, Mozziconacci MJ, Adélaïde J, Garnier S, Guille A, Murati A, Chaffanet M, Vey N, Birnbaum D, Gelsi-Boyer V.

Blood Cancer J. 2017 Aug 25;7(8):e594. doi: 10.1038/bcj.2017.68. No abstract available.

Supplemental Content

Loading ...
Support Center